Related Experiment Video
Updated: Feb 28, 2026

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
[Fat emulsion tolerance in preterm infants of different gestational ages in the early stage after birth]
Hui Tang1, Chuan-Zhong Yang, Huan Li
1Department of Neonatology, Shenzhen Maternity and Child Health Care Hospital Affiliated to Southern Medical University, Shenzhen, Guangdong 518028, China. yangczgd@163.com.
Insights
Extremely preterm infants have a reduced ability to metabolize long-chain fatty acids shortly after birth. These infants may not tolerate high-dose fat emulsions, unlike moderate-to-late preterm infants.
Area of Science:
- Neonatalogy
- Biochemistry
- Pediatric Nutrition
Background:
- Preterm infants require nutritional support, including fat emulsions, for growth and development.
- Fat metabolism capacity varies with gestational age in neonates.
- Understanding early fat emulsion tolerance is crucial for optimizing neonatal care.
Purpose of the Study:
- To assess fat emulsion tolerance in preterm infants based on gestational age.
- To investigate the relationship between gestational age and acylcarnitine profiles.
- To determine optimal fat emulsion dosing in early neonatal periods for different preterm groups.
Main Methods:
- 98 preterm infants categorized by gestational age: extremely preterm, early preterm, and moderate-to-late preterm.
- Analysis of short-, medium-, and long-chain acylcarnitines using tandem mass spectrometry.
- Comparison of acylcarnitine levels in umbilical cord blood and dried blood spots within 3 days post-birth, stratified by fat emulsion dose.
Main Results:
- Extremely and early preterm infants showed lower long-chain acylcarnitines than moderate-to-late preterm infants, correlating positively with gestational age.
- In extremely preterm infants, lower fat emulsion doses were associated with higher acylcarnitine levels on day 2.
- No significant differences in acylcarnitine levels were observed between low- and high-dose fat emulsion subgroups in early and moderate-to-late preterm infants.
Conclusions:
- Extremely and early preterm infants exhibit diminished long-chain fatty acid metabolism capacity within 3 days post-birth.
- Early and moderate-to-late preterm infants appear to tolerate high-dose fat emulsions.
- Extremely preterm infants may have impaired capacity to metabolize high-dose fat emulsions in the early neonatal period.
Objective:
To investigate the fat emulsion tolerance in preterm infants of different gestational ages in the early stage after birth.
Methods:
A total of 98 preterm infants were enrolled and divided into extremely preterm infant group (n=17), early preterm infant group (n=48), and moderate-to-late preterm infant group (n=33). According to the dose of fat emulsion, they were further divided into low- and high-dose subgroups. The umbilical cord blood and dried blood filter papers within 3 days after birth were collected. Tandem mass spectrometry was used to measure the content of short-, medium-, and long-chain acylcarnitines.
Results:
The extremely preterm infant and early preterm infant groups had a significantly lower content of long-chain acylcarnitines in the umbilical cord blood and dried blood filter papers within 3 days after birth than the moderate-to-late preterm infant group (P<0.05), and the content was positively correlated with gestational age (P<0.01). On the second day after birth, the low-dose fat emulsion subgroup had a significantly higher content of short-, medium-, and long-chain acylcarnitines than the high-dose fat emulsion subgroup among the extremely preterm infants (P<0.05). In the early preterm infant and moderate-to-late preterm infant groups, there were no significant differences in the content of short-, medium-, and long-chain acylcarnitines between the low- and high-dose fat emulsion subgroups within 3 days after birth.
Conclusions:
Compared with moderate-to-late preterm infants, extremely preterm infants and early preterm infants have a lower capacity to metabolize long-chain fatty acids within 3 days after birth. Early preterm infants and moderate-to-late preterm infants may tolerate high-dose fat emulsion in the early stage after birth, but extremely preterm infants may have an insufficient capacity to metabolize high-dose fat emulsion.
More Related Videos
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...